Literature DB >> 11269396

Synthesis of Neu5Ac- and Neu5Gc-alpha-(2-->6')-lactosamine 3-aminopropyl glycosides.

A A Sherman1, O N Yudina, A S Shashkov, V M Menshov, N E Nifant'ev.   

Abstract

In order to prepare 3-aminopropyl glycosides of Neu5Ac-alpha-(2-->6')-lactosamine trisaccharide 1, and its N-glycolyl containing analogue Neu5Gc-alpha-(2-->6')-lactosamine 2, a series of lactosamine acceptors with two, three, and four free OH groups in the galactose residue was studied in glycosylations with a conventional sialyl donor phenyl [methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-alpha- and beta-D-galacto-2-nonulopyranosid]onates (3) and a new donor phenyl [methyl 4,7,8,9-tetra-O-acetyl-5-(N-tert-butoxycarbonylacetamido)-3,5-dideoxy-2-thio-D-glycero-alpha- and beta-D-galacto-2-nonulopyranosid]onates (4), respectively. The lactosamine 4',6'-diol acceptor was found to be the most efficient in glycosylation with both 3 and 4, while imide-type donor 4 gave slightly higher yields with all acceptors, and isolation of the reaction products was more convenient. In the trisaccharides, obtained by glycosylation with donor 4, the 5-(N-tert-butoxycarbonylacetamido) moiety in the neuraminic acid could be efficiently transformed into the desired N-glycolyl fragment, indicating that such protected oligosaccharide derivatives are valuable precursors of sialo-oligosaccharides containing N-modified analogues of Neu5Ac.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269396     DOI: 10.1016/s0008-6215(01)00002-7

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  The chemical synthesis of human milk oligosaccharides: Lacto-N-tetraose (Galβ1→3GlcNAcβ1→3Galβ1→4Glc).

Authors:  Mithila D Bandara; Keith J Stine; Alexei V Demchenko
Journal:  Carbohydr Res       Date:  2019-09-25       Impact factor: 2.104

Review 2.  Synthesis of N-Glycolylneuraminic Acid (Neu5Gc) and Its Glycosides.

Authors:  Anoopjit Singh Kooner; Hai Yu; Xi Chen
Journal:  Front Immunol       Date:  2019-08-28       Impact factor: 7.561

Review 3.  Perspectives for the Use of Fucoidans in Clinical Oncology.

Authors:  Mikhail V Kiselevskiy; Natalia Yu Anisimova; Nadezhda E Ustyuzhanina; Dmitry Z Vinnitskiy; Alexandra I Tokatly; Vera V Reshetnikova; Irina O Chikileva; Irina Zh Shubina; Kirill I Kirgizov; Nikolay E Nifantiev
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.